NASDAQ: KYMR Kymera Therapeutics, Inc. 8-K

Kymera COO Jeremy Chadwick resigns, will stay on as advisor through November

Filed June 8, 2026 · Period ending June 5, 2026 · ~1 min read

Key Changes

  • medium

    Chief Operating Officer Jeremy Chadwick resigned effective June 5, 2026, but will remain with the company as an advisor through November 2026, providing continuity during the leadership transition.

  • low

    The company disclosed the resignation was for personal reasons and not due to any disagreement with company practices or policies, indicating an amicable departure.

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (HOTH 10-Q) is open in full — no account needed.

Partner

Trade KYMR commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 10, 2026 5:09 PM